<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rsc="urn:rsc.org" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Mesoporous NiS 2 nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal–chemotherapy   - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C8TB02473A</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/tb/c8tb02473a"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":66,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Gang He"/><meta name="DC.Creator" content="Yan Ma"/><meta name="DC.Creator" content="Hu Zhou"/><meta name="DC.Creator" content="Siyuan Sun"/><meta name="DC.Creator" content="Xianwen Wang"/><meta name="DC.Creator" content="Haisheng Qian"/><meta name="DC.Creator" content="Yan Xu"/><meta name="DC.Creator" content="Zhaohua Miao"/><meta name="DC.Creator" content="Zhengbao Zha"/><meta name="DC.title" content="Mesoporous NiS 2 nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal–chemotherapy  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2018/12/19"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C8TB02473A"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Mesoporous NiS 2 nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal–chemotherapy  "/><meta name="citation_author" content="Gang He"/><meta name="citation_author" content="Yan Ma"/><meta name="citation_author" content="Hu Zhou"/><meta name="citation_author" content="Siyuan Sun"/><meta name="citation_author" content="Xianwen Wang"/><meta name="citation_author" content="Haisheng Qian"/><meta name="citation_author" content="Yan Xu"/><meta name="citation_author" content="Zhaohua Miao"/><meta name="citation_author" content="Zhengbao Zha"/><meta name="citation_online_date" content="2018/11/21"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="Journal of Materials Chemistry B"/><meta name="citation_volume" content="7"/><meta name="citation_issue" content="1"/><meta name="citation_firstpage" content="143"/><meta name="citation_lastpage" content="149"/><meta name="citation_doi" content="10.1039/C8TB02473A"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/tb/c8tb02473a"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/tb/c8tb02473a"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/tb/c8tb02473a"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/tb/c8tb02473a">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c8tb02724b)" href="/en/content/articlehtml/2019/tb/c8tb02724b" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c8tb02264j)" href="/en/content/articlehtml/2019/tb/c8tb02264j" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C8TB02473A">10.1039/C8TB02473A</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2050-7518/2013">J. Mater. Chem. B</a></span>, 2019, <strong>7</strong>, 143-149</div><h1 id="sect195"><span class="title_heading">Mesoporous NiS<small><sub>2</sub></small> nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal–chemotherapy<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Gang 
            He<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yan 
            Ma<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Hu 
            Zhou<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">b</span></sup>, 
      <span class="bold">
        
          
            Siyuan 
            Sun
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Xianwen 
            Wang
          
        
      </span>*<sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Haisheng 
            Qian
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Haisheng Qian (orcid.org/0000-0003-4903-3447) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-4903-3447"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yan 
            Xu
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Zhaohua 
            Miao
          
        
      </span>*<sup><span class="sup_ref italic">a</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Zhengbao 
            Zha
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Zhengbao Zha (orcid.org/0000-0003-3646-4969) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-3646-4969"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">a</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, P. R. China. E-mail: <a href="mailto:xianwenwang@mail.hfut.edu.cn">xianwenwang@mail.hfut.edu.cn</a>; <a href="mailto:zhaohua_miao@hfut.edu.cn">zhaohua_miao@hfut.edu.cn</a>; <a href="mailto:zbzha@hfut.edu.cn">zbzha@hfut.edu.cn</a>;   Tel: +86 551 62901285</span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">The First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui 230001, P. R. China</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      19th September 2018
    </span><span class="bold italic">, Accepted 20th November 2018</span></div><p class="bold italic">First published on 21st November 2018</p><hr/><div class="abstract"><h2>Abstract</h2><p>To overcome the unfavorable effects of the hydrophobicity of drugs and cancer resistance, mesoporous NiS<small><sub>2</sub></small> nanospheres (mNiS<small><sub>2</sub></small> NSs) have been successfully developed here to package hydrophobic camptothecin (CPT) and realize the synergistic photothermal–chemotherapy of cancer. The mNiS<small><sub>2</sub></small> NSs which were prepared through a facile solvothermal method here exhibited not only considerable near-infrared (NIR) absorption and good photothermal conversion efficiency as high as 44.6%, but also achieved a NIR light induced CPT release property which were both beneficial for improving the cancer cell-killing efficacy. After a short period of NIR light illumination, a significant intensified cell killing efficacy was observed when 4T1 or HepG2 cancer cells were incubated with CPT@mNiS<small><sub>2</sub></small> NSs. Thus, mNiS<small><sub>2</sub></small> NSs have been demonstrated here to have potential as a novel NIR light-responsive hydrophobic drug delivery nanoplatform for realizing synergistic cancer treatment.</p></div><hr/>
    
      <h2 id="sect287"><span class="a_heading">Introduction</span></h2>
      <span>Cancer, a disease with a high mortality rate, has become one of the most challenging problems in the world.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–3</span></sup></a> Although chemotherapy has occupied an indispensable position in the adjuvant treatment of cancer, its efficacy still needs to be further improved owing to some barriers, including the hydrophobic properties of chemical substances and various physiological barriers for drug delivery as well as drug resistance.<a title="Select to navigate to reference" href="#cit4"><sup><span class="sup_ref">4,5</span></sup></a> Currently, nearly 40% of the produced chemical anticancer drugs suffer from poor water solubility and consequently result in a significant barrier for intravenous administration.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> For instance, camptothecin (CPT), an effective chemical substance in the treatment of various carcinomas, has limited clinical applications due to its poor dispersity in a physiological medium.<a title="Select to navigate to reference" href="#cit7"><sup><span class="sup_ref">7–10</span></sup></a> A universal strategy is to use a water-soluble salt formulation of CPT with different physicochemical characteristics for intravenous injection, but these chemical modifications may lead to unexpected changes in either the antitumor activity or toxicological profile.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11–13</span></sup></a> To date, nanoparticle technology has gained considerable attention in oncology due to its potential of delivering hydrophobic anticancer drugs into tumor lesions with enhanced therapeutic outcomes and reduced adverse effects.<a title="Select to navigate to reference" href="#cit14"><sup><span class="sup_ref">14–16</span></sup></a> To be realistic, the currently developed nanocarrier formulations still have room for improvement in increasing the drug loading capacity and their responsiveness to some specific stimuli for realizing controlled drug release.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17–19</span></sup></a> Thus, developing novel stimuli-responsive hydrophobic drug delivery systems to realize controlled and sustained drug release profiles is highly desirable.</span>
      <p class="otherpara">It is generally accepted that single chemotherapy cannot erase cancer completely due to the complicated and interconnected disease pathways of cancer, resulting in the emergence of drug resistance and tumor recurrence.<a title="Select to navigate to reference" href="#cit20"><sup><span class="sup_ref">20–22</span></sup></a> Encouraged by the fact that hyperthermia could facilitate the cellular uptake of chemotherapeutic drugs, combined thermo-chemo therapy would result in an enhanced therapeutic outcome and reduced side effects.<a title="Select to navigate to reference" href="#cit23"><sup><span class="sup_ref">23–25</span></sup></a> Recently, near-infrared (NIR) light induced photothermal therapy (PTT), which can utilize light-absorbing agents to directly convert the energy of incident light into hyperthermia to locally “boil” cancer cells, has attracted great interest in combating cancer due to its minimal invasiveness and high selectivity.<a title="Select to navigate to reference" href="#cit26"><sup><span class="sup_ref">26–29</span></sup></a> Thus, there would be unique advantages to integrate photothermal agents and chemotherapeutic drugs into a single nanoplatform. Up to now, although various nanoplatforms have been successfully constructed for combined photothermal–chemotherapy,<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30–33</span></sup></a> the non-biodegradable characteristic of these reported inorganic nanoplatforms has hampered their clinical translation due to long-term safety concerns. Therefore, still there is an enormous demand for the development of novel degradable photothermal nanoplatforms for hydrophobic drug delivery to achieve efficient cancer cell-killing.</p>
      <p class="otherpara">Recently, due to their unique physicochemical properties as well as low cost, nickel-containing nanomaterials have received great attention in various fields, including batteries, catalysis, biomedical sensors and solar cells.<a title="Select to navigate to reference" href="#cit34"><sup><span class="sup_ref">34–37</span></sup></a> For instance, Ni-integrated CuS nanoparticles were developed as a novel photoacoustic (PA)/magnetic resonance imaging (MRI) contrast agent by a doping method.<a title="Select to navigate to references" href="#cit38"><sup><span class="sup_ref">38</span></sup></a> PEGylated nickel carbide nanocrystals (Ni<small><sub>3</sub></small>C NCs) were demonstrated as an effective PTT agent for cancer therapy <span class="italic">in vivo</span>.<a title="Select to navigate to references" href="#cit39"><sup><span class="sup_ref">39</span></sup></a> Another paradigm is that nickel oxide nanoparticles (NiO NPs) were reported for combined photodynamic therapy and chemotherapy.<a title="Select to navigate to references" href="#cit40"><sup><span class="sup_ref">40</span></sup></a> In our previous work, polyacrylic acid-functionalized Ni<small><sub>0.85</sub></small>Se nanoparticles were successfully constructed to realize PA imaging guided photothermal–chemo treatment of cancer.<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> Very recently, monodispersed mesoporous NiS<small><sub>2</sub></small> nanospheres (mNiS<small><sub>2</sub></small> NSs) have been developed <span class="italic">via</span> a facile solvothermal process for producing high-rate and long-life sodium-ion batteries.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> To the best of our knowledge, developing mNiS<small><sub>2</sub></small> NSs as a hydrophobic drug delivery nanoplatform for combined photothermal–chemotherapy owing to their good mesoporous structure has not been reported yet.</p>
      <p class="otherpara">In this study, monodispersed mNiS<small><sub>2</sub></small> NSs were prepared <span class="italic">via</span> a facile template-free solvothermal process according to a reported method with minor modifications (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1a</a>).<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> The as-prepared mNiS<small><sub>2</sub></small> NSs exhibited considerable NIR absorption, gradual degradation and high photothermal conversion efficiency. Moreover, the mesoporous nanostructure could render mNiS<small><sub>2</sub></small> NSs the ability for loading hydrophobic CPT owing to their high specific surface area. Upon NIR laser irradiation, the mNiS<small><sub>2</sub></small> NSs could achieve not only thermo-responsive CPT release, but also synergistic photothermal–chemotherapy for killing cancer cells (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1b</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-s1.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Schematic illustration of CPT@mNiS<small><sub>2</sub></small> NSs, (a) preparation process and (b) synergistic photothermal–chemotherapy.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      <h2 id="sect328"><span class="a_heading">Experimental section</span></h2>
      
        <h3 id="sect330"><span class="b_heading">Materials</span></h3>
        <span>Nickel nitrate hexahydrate (Ni(NO<small><sub>3</sub></small>)<small><sub>2</sub></small>·6H<small><sub>2</sub></small>O) was bought from Aladdin Chemical Reagent Co., Ltd. Ethylene glycol (EG), sodium thiosulfate pentahydrate (Na<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>3</sub></small>·5H<small><sub>2</sub></small>O) and polyvinylpyrrolidone (PVP, K30) were obtained from Sinopharm Chemical Reagent Co., Ltd. Anticancer drug CPT was obtained from Beijing Huafeng United Technology Co., Ltd. Deionized water (DI water) with a resistivity of 18.2 MΩ cm was used for all the experiments.</span>
      
      
        <h3 id="sect340"><span class="b_heading">Synthesis of mNiS<small><sub>2</sub></small> NSs</span></h3>
        <span>mNiS<small><sub>2</sub></small> NSs were prepared <span class="italic">via</span> a reported solvothermal method with minor modifications.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> Typically, 0.6 g PVP, 2 mmol Ni(NO<small><sub>3</sub></small>)<small><sub>2</sub></small>·6H<small><sub>2</sub></small>O and 6 mmoL Na<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>3</sub></small>·5H<small><sub>2</sub></small>O were completely dissolved in a mixed solvent of 80 mL EG and DI water (1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 v:v) under magnetic stirring for 1 h. Thereafter, the mixed solution was sealed in an autoclave and stewed at 180 °C for 12 h. The final product (mNiS<small><sub>2</sub></small> NSs) was obtained through standard centrifugation/washing cycles.</span>
      
      
        <h3 id="sect355"><span class="b_heading">Characterizations of mNiS<small><sub>2</sub></small> NSs</span></h3>
        <span>The surface chemical composition and crystallographic structure of the as-prepared mNiS<small><sub>2</sub></small> NSs were examined by X-ray photoelectron spectroscopy (XPS, ESCALab 250Xi, USA) and X-ray diffraction (XRD, PANalytical B. V., Holland). Scanning electron microscopy (SEM, Hitachi S-4800, Japan) and transmission electron microscopy (TEM, JEM-2100F, Japan) were used to characterize the morphology of the mNiS<small><sub>2</sub></small> NSs. The hydrodynamic diameter and size distribution were recorded using a NanoBrook-90 Plus instrument. The Brunauer–Emmett–Teller (BET) surface area was measured by using an Autosorb IQ3 instrument.</span>
      
      
        <h3 id="sect361"><span class="b_heading">Photothermal effect of mNiS<small><sub>2</sub></small> NSs under NIR irradiation</span></h3>
        <span>To investigate the photothermal conversion effect, mNiS<small><sub>2</sub></small> NS aqueous solutions with gradient concentrations were illuminated with NIR light (808 nm, 2.0 W cm<small><sup>−2</sup></small>) for 10 min. In consideration of the demand of repeated cancer treatments during PTT, five laser on/off cycles were also used to evaluate the photo-stability of the mNiS<small><sub>2</sub></small> NSs. Moreover, the photothermal conversion efficiency of the mNiS<small><sub>2</sub></small> NSs was calculated according to the methods previously described.<a title="Select to navigate to reference" href="#cit41"><sup><span class="sup_ref">41,42</span></sup></a></span>
      
      
        <h3 id="sect370"><span class="b_heading">
          <span class="italic">In vitro</span> CPT loading and releasing</span></h3>
        <span>For CPT loading, 5 mg mNiS<small><sub>2</sub></small> NSs and 20 mg CPT were dispersed and stirred in 3 mL dimethyl sulfoxide (DMSO) at ambient atmosphere. After 24 h, the CPT loaded mNiS<small><sub>2</sub></small> NSs (CPT@mNiS<small><sub>2</sub></small> NSs) were obtained through centrifugation and washed with phosphate buffer solution (PBS, pH = 7.4) three times. The concentration of CPT contained in the supernatant was calculated by determining the absorbance at 367 nm. The loading capacity (LC) was estimated as follows: LC (%) = (weight of whole CPT − weight of CPT in the discard solution)/(weight of NSs + weight of CPT loaded into the NSs) × 100%.</span>
        <p class="otherpara">The <span class="italic">in vitro</span> CPT release profile from CPT@mNiS<small><sub>2</sub></small> NSs was investigated under different conditions. In detail, 1 mg CPT@mNiS<small><sub>2</sub></small> NSs was first suspended in 1 mL DI water and then sealed in a dialysis bag (<span class="italic">M</span><small><sub>w</sub></small> = 3500) which was immersed in a centrifuge tube containing 30 mL PBS (pH = 7.4, 6.0 or 5.0) at 37 °C or 50 °C. At predetermined time intervals, typical sampling and replenish cycles were performed to monitor the release profile of CPT. Moreover, NIR laser illumination was further executed to assess the influence of NIR light/heat on the CPT release properties from CPT@mNiS<small><sub>2</sub></small> NSs.</p>
      
      
        <h3 id="sect384"><span class="b_heading">Cell study</span></h3>
        <span>The biocompatibility of the as-prepared mNiS<small><sub>2</sub></small> NSs was assessed through a typical MTT assay by using human cervical vein endothelial cells (HUVECs). A hemolysis test was also carried out to evaluate the hematotoxicity of the mNiS<small><sub>2</sub></small> NSs by using the blood of healthy mice according to a previously reported method.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a></span>
        <p class="otherpara">The localized photothermal cancer cell ablation ability of the mNiS<small><sub>2</sub></small> NSs was further evaluated by irradiating 4T1 breast cancer cells with a NIR laser (808 nm, 2.0 W) and standard live/dead cell staining assay (green fluorescence from calcein-AM for live cells and red fluorescence from propidium iodide (PI) for dead cells). Furthermore, the intensified cell-killing effect from combined photothermal–chemotherapy was quantitatively investigated by a standard MTT assay.</p>
      
    
    
      <h2 id="sect392"><span class="a_heading">Results and discussion</span></h2>
      
        <h3 id="sect394"><span class="b_heading">Characterization of mNiS<small><sub>2</sub></small> NSs</span></h3>
        <span>According to a reported study,<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> the formation mechanism for mNiS<small><sub>2</sub></small> NSs is that NiS<small><sub>2</sub></small> is solvothermally synthesized by reaction of S<small><sub>2</sub></small>O<small><sub>3</sub></small><small><sup>2−</sup></small> and Ni<small><sup>2+</sup></small>, in which S<small><sub>2</sub></small>O<small><sub>3</sub></small><small><sup>2−</sup></small> is used as both a sulfur source and a reducing agent. Solvent EG would be converted into acetaldehyde at high temperature, which serves as an oxidizing agent in the formation of NiS<small><sub>2</sub></small> nuclei. Due to the amphipathic nature of PVP stabilizers, the NiS<small><sub>2</sub></small> nuclei tend to absorb on the carbonyl groups of PVP, and then gradually become more tightly packed. With further processing, hierarchical spherical shaped mNiS<small><sub>2</sub></small> NSs form by oligomerization of tiny nanocrystals <span class="italic">via</span> the LaMer scheme.<a title="Select to navigate to references" href="#cit44"><sup><span class="sup_ref">44</span></sup></a> As shown in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1a</a>, the SEM image of the as-prepared mNiS<small><sub>2</sub></small> NSs clearly showed a regular spherical morphology and good monodispersity with an average diameter of 102.2 ± 24.4 nm. Moreover, each mNiS<small><sub>2</sub></small> NS was composed of tightly piled NiS<small><sub>2</sub></small> nanocrystals with ultrasmall size, confirming the reasonability of the deductive formation mechanism of mNiS<small><sub>2</sub></small> NSs. In addition, the TEM characterization further revealed that mNiS<small><sub>2</sub></small> NSs have a highly ordered pore structure, due to the spherical packing of NiS<small><sub>2</sub></small> nanocrystals (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1b and c</a>). The lattice fringes of NiS<small><sub>2</sub></small> display an interplanar spacing of 0.198 nm, which is in good agreement with the (220) planes of the cubic NiS<small><sub>2</sub></small>.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f1.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Characterization of the as-prepared mNiS<small><sub>2</sub></small> NSs. (a) SEM (inset: diameter distribution) and (b) TEM image; (c) HRTEM image; (d) XRD patterns (inset: the SAED image); (e) nitrogen adsorption–desorption isotherm of mNiS<small><sub>2</sub></small> NSs (inset: pore size distribution); (f) EDS analysis; (g) STEM elemental mappings of Ni and S and the merged image of Ni and S elements.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Moreover, the phase structure of the as-prepared product was further characterized by XRD analysis (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1d</a>), showing that all diffraction peaks containing the (111), (200), (210), (211), (220), (331), (222), (023) and (321) faces could be clearly assigned to the cubic NiS<small><sub>2</sub></small> phase (JCPDS no. 65-3325), was confirmed by the results of the SAED pattern (inset of <a title="Select to navigate to figure" href="#imgfig1">Fig. 1d</a>). A relatively high specific BET surface area (34.0 m<small><sup>2</sup></small> g<small><sup>−1</sup></small>) was observed (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1e</a>), and the average pore size was calculated to be 3.4 nm (inset of <a title="Select to navigate to figure" href="#imgfig1">Fig. 1e</a>), indicating the mesoporous structure of the as-prepared mNiS<small><sub>2</sub></small> NSs which is good for encapsulating anticancer drugs. In addition, as shown in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1f</a>, except the signals of Cu, O, and C elements which were mainly from air or the sample-support substrate for the measurement, the EDS results further verify the presence of Ni and S at a molar ratio of around 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1.8, indicating the composition of NiS<small><sub>2</sub></small> which is further confirmed by the results of elemental mapping showed that both Ni and S elements were evenly distributed throughout the whole nanospheres (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1g</a>). Further confirmed by the results of inductively coupled plasma atomic emission spectrometry (ICP-AES, as 100 μg mL<small><sup>−1</sup></small> of NPs consisted of 43.3 and 47.1 μg mL<small><sup>−1</sup></small> of nickel and sulfur elements, respectively), a Ni/S stoichiometry was calculated to be 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>2 which demonstrated the formation of the NiS<small><sub>2</sub></small> phase.</p>
        <p class="otherpara">Moreover, XPS measurements were also performed to further analyze the surface electronic states and elemental composition of mNiS<small><sub>2</sub></small> NSs (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2a–d</a>). In the Ni 2p spectra (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2a</a>), the binding energies of Ni 2p<small><sub>1/2</sub></small> and Ni 2p<small><sub>3/2</sub></small> for the mNiS<small><sub>2</sub></small> NSs are observed at about 870.68 and 853.58 eV, respectively, along with two satellite peaks (abbreviated as Sat.) at about 876.38 and 859.68 eV.<a title="Select to navigate to references" href="#cit45"><sup><span class="sup_ref">45</span></sup></a> In the S 2p spectra (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2b</a>), the peaks at about 162.28 and 163.47 eV are assigned to S 2p<small><sub>1/2</sub></small> and S 2p<small><sub>3/2</sub></small> of S<small><sub>2</sub></small><small><sup>2−</sup></small>, respectively, indicating the presence of S–S bonds in the mNiS<small><sub>2</sub></small> NSs. Besides, the peaks at 168.64 eV can be attributed to S–O bonding owing to the surface oxidation of the mNiS<small><sub>2</sub></small> NSs.<a title="Select to navigate to references" href="#cit46"><sup><span class="sup_ref">46</span></sup></a> In the C 1s spectra (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2c</a>), the strong peak at 284.83 eV is attributed to C 1s, and it may mainly come from the PVP molecules on the surface of the mNiS<small><sub>2</sub></small> NSs. All the binding energies are closer to the previously reported values. In addition, XPS survey spectra show the presence of O 1s due to its exposure to oxygen present in air (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2d</a>). The XPS analysis further confirmed the formation of cubic NiS<small><sub>2</sub></small>, which is consistent with the XRD data of the mNiS<small><sub>2</sub></small> NSs.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f2.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">XPS characterization. The core level spectrum of (a) Ni 2p; (b) S 2p; (c) C 1s; (d) the survey spectrum.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        <h3 id="sect465"><span class="b_heading">Photothermal conversion performance and <span class="italic">in vitro</span> CPT release</span></h3>
        <span>Due to the importance of the storage stability of nanomaterials for biomedical applications to avoid any adverse effect, the stabilities of the mNiS<small><sub>2</sub></small> NSs in various media including DI water, PBS with different pH and DMEM cell culture medium were investigated. As shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>, owing to the inherent hydrophilicity of PVP stabilizers, no significant diameter change of mNiS<small><sub>2</sub></small> NSs was observed in various media for one week (4 °C and room temperature) and there were no significant absorbance decrease and observable macroscopic aggregates (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a> and Fig. S1, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), indicating their good storage stability for biomedical applications. Thereafter, the UV-vis-NIR spectrum of the mNiS<small><sub>2</sub></small> NS aqueous solution exhibited a strong and broad absorption in the whole range from 300 to 1000 nm (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3c</a>), with a calculated mass extinction coefficient of 10.9 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> at 808 nm based on the Lambert–Beer law,<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> which is comparable to those of some reported inorganic nanomaterials, such as Au nanorods (13.9 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> at 808 nm),<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> graphene oxide (7.9 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> at 808 nm),<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> and platinum–copper alloy nanoparticles (6.3 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> at 808 nm).<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f3.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Characterization of the mNiS<small><sub>2</sub></small> NSs. The storage stability of the mNiS<small><sub>2</sub></small> NSs in various media at 4 °C: (a) hydrodynamic diameter distribution and (b) relative absorbance at 808 nm of mNiS<small><sub>2</sub></small> NSs (inset: photographs of mNiS<small><sub>2</sub></small> NSs); (c) UV-vis-NIR absorption spectra (inset: photographs of mNiS<small><sub>2</sub></small> NS aqueous solution); temperature elevation of mNiS<small><sub>2</sub></small> NS aqueous solutions with different (d) concentrations and (e) power of the NIR laser; (f) photo-stability characterization through five laser on/off cycles; (g) UV-vis-NIR absorption spectra; (h) photothermal profile and (i) time constant of mNiS<small><sub>2</sub></small> NS dispersion (3.0 mL, 20 μg mL<small><sup>−1</sup></small>) irradiated by the NIR laser for 25 min, followed by natural cooling to ambient temperature.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Next, the temperatures of 3.0 mL mNiS<small><sub>2</sub></small> NS aqueous solutions with various concentrations (10, 20, 30, 40 and 50 μg mL<small><sup>−1</sup></small>) were recorded under NIR light illumination (808 nm, 2.0 W cm<small><sup>−2</sup></small>). After continuously being illuminated for 10 min, the temperature was increased from 29.7 °C to 37.1 °C, 42.7 °C, 45.7 °C, 48.1 °C, and 51.4 °C, respectively, indicating an obvious concentration-dependent manner (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3d</a>). In contrast, the temperature of DI water was increased by only 0.9 °C with the same treatment. Similarly, the temperature of the mNiS<small><sub>2</sub></small> NS aqueous solution (50 μg mL<small><sup>−1</sup></small>) was monitored under 808 nm laser irradiation with various power, and a distinct incident-energy dependent performance was also observed (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3e</a>). Moreover, to assess the photo-stability of the as-prepared mNiS<small><sub>2</sub></small> NSs for the potential repeated PTT and on-demand drug release, five laser on/off cycles were used by irradiating mNiS<small><sub>2</sub></small> NSs aqueous solution (50 μg mL<small><sup>−1</sup></small>) with an NIR laser, followed by natural cooling to ambient temperature without illumination. No significant change in temperature elevation and UV-vis-NIR absorption spectra was observed before and after five irradiation cycles, demonstrating the good photo-stability of the mNiS<small><sub>2</sub></small> NSs (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3f and g</a>). In addition, according to a reported method,<a title="Select to navigate to references" href="#cit50"><sup><span class="sup_ref">50</span></sup></a> the photothermal conversion efficiency of the mNiS<small><sub>2</sub></small> NSs was calculated to be 44.6% (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3h and i</a>), which is higher than those of other reported inorganic nanomaterials, such as Cu<small><sub>3</sub></small>BiS<small><sub>3</sub></small> hollow nanospheres (27.5% at 980 nm),<a title="Select to navigate to references" href="#cit51"><sup><span class="sup_ref">51</span></sup></a> Cu<small><sub>2−<span class="italic">x</span></sub></small>Se nanocrystals (22% at 800 nm),<a title="Select to navigate to references" href="#cit52"><sup><span class="sup_ref">52</span></sup></a> MoO<small><sub>3−<span class="italic">x</span></sub></small> hollow nanospheres (22.64% at 808 nm),<a title="Select to navigate to references" href="#cit53"><sup><span class="sup_ref">53</span></sup></a> Ni<small><sub>3</sub></small>C nanocrystals (16.9% at 800 nm)<a title="Select to navigate to references" href="#cit39"><sup><span class="sup_ref">39</span></sup></a> and Prussian blue nanoparticles (36.7% at 808 nm).<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> Therefore, these data indicated that mNiS<small><sub>2</sub></small> NSs could act as a potential photothermal agent for cancer treatment.</p>
        <p class="otherpara">The non-biodegradable characteristic of many reported inorganic nanomaterials hampered their further clinical translation due to long-term toxicological concerns. In this study, mNiS<small><sub>2</sub></small> NS aqueous solutions were selectively exposed to dissolved oxygen, H<small><sub>2</sub></small>O<small><sub>2</sub></small> (50 μM, mimic the tumor microenvironment) and a nitrogen atmosphere at 37 °C to investigate the oxidation and degradation performance of the as-prepared mNiS<small><sub>2</sub></small> NSs. As shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4a and b</a>, a gradual decrease in the hydrodynamic diameter and absorbance and the solution color change from brown to transparent were observed when mNiS<small><sub>2</sub></small> NSs came into contact with dissolved oxygen and H<small><sub>2</sub></small>O<small><sub>2</sub></small>, indicating the occurrence of the oxidation-induced degradation process of the mNiS<small><sub>2</sub></small> NSs. In contrast, the mNiS<small><sub>2</sub></small> NS solutions kept in the nitrogen atmosphere showed no significant change in color, hydrodynamic diameter and absorbance, suggesting that oxygen/H<small><sub>2</sub></small>O<small><sub>2</sub></small> should be a vital factor in the degradation process of the mNiS<small><sub>2</sub></small> NSs. The gradual oxidation and degradation performance of the mNiS<small><sub>2</sub></small> NSs when exposed to dissolved oxygen and H<small><sub>2</sub></small>O<small><sub>2</sub></small> would allow them to be used as a degradable nanoplatform due to the relatively high concentration of dissolved oxygen in blood and H<small><sub>2</sub></small>O<small><sub>2</sub></small> in the tumor microenvironment. Thereafter, typical hemolysis and MTT assays were both performed to investigate the cytotoxicity of the mNiS<small><sub>2</sub></small> NSs. As shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4c</a>, the mNiS<small><sub>2</sub></small> NSs showed no observable hemolysis effect with a concentration as high as 200 μg mL<small><sup>−1</sup></small>, demonstrating their safety when circulated in the blood pool. Additionally, a typical MTT assay was used to characterize the cell viability of HUVECs when incubated with mNiS<small><sub>2</sub></small> NSs as long as 48 h. As expected, the as-prepared mNiS<small><sub>2</sub></small> NSs were largely biocompatible as the relative cell viability remains exceeding 90% in comparison to negative groups as incubated with 200 μg mL<small><sup>−1</sup></small> of mNiS<small><sub>2</sub></small> NSs for 48 h (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4d</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f4.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Characterization of CPT@mNiS<small><sub>2</sub></small> NSs. The gradual oxidation and degradation performance of mNiS<small><sub>2</sub></small> NS aqueous solution when exposed to air, H<small><sub>2</sub></small>O<small><sub>2</sub></small> (50 μM) and N<small><sub>2</sub></small>: (a) hydrodynamic diameter distribution and (b) relative absorbance at 808 nm (inset: photographs of 40 μg mL<small><sup>−1</sup></small> mNiS<small><sub>2</sub></small> NSs aqueous solution); (c) hemolysis assay; (d) cell viability of HUVECs after incubation with mNiS<small><sub>2</sub></small> NSs for 24 and 48 h; (e) UV-vis-NIR spectra and (f) hydrodynamic diameter distribution of CPT@mNiS<small><sub>2</sub></small> NSs; (g) fluorescence spectra of free CPT and CPT@mNiS<small><sub>2</sub></small> NSs; <span class="italic">in vitro</span> CPT release profiles from CPT@mNiS<small><sub>2</sub></small> NSs under (h) various pH at 37 or 50 °C and (i) NIR laser irradiation.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Afterwards, inspired by the good photothermal conversion efficiency and biocompatibility of mNiS<small><sub>2</sub></small> NSs, the potential of the mNiS<small><sub>2</sub></small> NSs as a hydrophobic drug delivery vehicle has been revealed due to the amphipathic nature of PVP stabilizers which distributed on all of the pore structures. Compared to free CPT and mNiS<small><sub>2</sub></small> NSs, the obtained CPT@mNiS<small><sub>2</sub></small> NSs acquired characteristic absorption of both free CPT and mNiS<small><sub>2</sub></small> NSs (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4e</a>), while no significant change of morphology (Fig. S2, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>) and hydrodynamic diameter (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4f</a>) occurred between mNiS<small><sub>2</sub></small> NSs and CPT@mNiS<small><sub>2</sub></small> NSs. Unlike the results of the UV-vis-NIR spectra, the fluorescence intensity of CPT in CPT@mNiS<small><sub>2</sub></small> NSs nearly disappeared when compared to that of free CPT with an equivalent amount, which could be visualized more easily from the fluorescence image (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4g</a>). This phenomenon was ascribed to the aggregated state of CPT in CPT@mNiS<small><sub>2</sub></small> NSs, demonstrating the successful CPT loading in mNiS<small><sub>2</sub></small> NSs (CPT loading capacity: 15.6%). The mesoporous structure of the mNiS<small><sub>2</sub></small> NSs (BET surface area of 25.2 m<small><sup>2</sup></small> g<small><sup>−1</sup></small>) and pore size (3.1 nm) were still preserved after CPT loading (Fig. S3, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), guaranteeing the successful release of loaded CPT. Thereafter, the <span class="italic">in vitro</span> CPT release profile was investigated by using a typical dialysis method. As seen in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4h</a>, unlike the temperature-responsive CPT release profile, no obvious pH-responsive CPT release behavior was observed which may be due to the fact that no acidic protonation or degradation of either CPT or mNiS<small><sub>2</sub></small> NSs occurred in a mild acidic environment. Different from the influence of the acidic environment, irradiation with an NIR laser would increase the accumulative release amount of CPT from about 18.0% to 30% during 12 h when incubated with neutral PBS owing to the accelerated molecular movement in a heated solution (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4i</a>).</p>
      
      
        <h3 id="sect592"><span class="b_heading">Synergistic cell-killing effect of CPT@mNiS<small><sub>2</sub></small> NSs</span></h3>
        <span>Encouraged by the good photothermal conversion efficiency and ability to deliver hydrophobic CPT, the synergistic cell-killing effect of the as-prepared CPT@mNiS<small><sub>2</sub></small> NSs was further evaluated. Firstly, localized photothermal destruction ability was qualitatively investigated by using 4T1 breast cancer cells. After various treatments with mNiS<small><sub>2</sub></small> NSs/free CPT or NIR laser irradiation, 4T1 cells were co-stained with calcein AM and PI to visualize live and dead cells. As seen in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>, strong red fluorescence was seen only in the presence of both mNiS<small><sub>2</sub></small> NSs and NIR laser irradiation, and the region of dead cells (red fluorescence) expanded as the concentration of mNiS<small><sub>2</sub></small> NSs and irradiation time increased. No acute cancer death was observed when 4T1 cells were treated with single NIR laser irradiation, free CPT or mNiS<small><sub>2</sub></small> NSs, similar to the negative group (largely green fluorescence). These data confirm that mNiS<small><sub>2</sub></small> NSs plus appropriate NIR laser irradiation would realize localized tumor ablation.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f5.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">Characterization of cell-killing efficiency. (a) Localized ablation of 4T1 cells stained by a typical live/dead assay; cell viability of 4T1 cancer cells treated with free CPT, mNiS<small><sub>2</sub></small> NSs and CPT@mNiS<small><sub>2</sub></small> NSs plus NIR laser irradiation for (b) 0 min; (c) 1 min; (d) 3 min.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">A standard MTT assay was further used to quantitatively investigate the synergistic cancer cell-killing effect of combined photothermal–chemotherapy. As depicted in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5b</a>, without NIR light illumination, mNiS<small><sub>2</sub></small> NSs showed low toxicity as the cell viability of 4T1 cancer cells remained exceeding 90% even after incubation with mNiS<small><sub>2</sub></small> NSs (150 μg mL<small><sup>−1</sup></small>) for 24 h. Due to the sustained CPT release from CPT@mNiS<small><sub>2</sub></small> NSs, CPT@mNiS<small><sub>2</sub></small> NSs exhibited relatively weak cell-killing efficiency in comparison to free CPT with an equivalent concentration. In contrast, significant cell death was observed when 4T1 cancer cells were treated with mNiS<small><sub>2</sub></small> NSs or CPT@mNiS<small><sub>2</sub></small> NSs plus NIR light irradiation due to the generation of hyperthermia, exhibiting a concentration/irradiation energy dependent manner. Importantly, the CPT@mNiS<small><sub>2</sub></small> NSs plus NIR laser irradiation exhibited a synergistic cell-killing effect in comparison to single chemotherapy (free CPT) or PTT (mNiS<small><sub>2</sub></small> NSs plus NIR laser irradiation). For instance, with 1 min of NIR laser irradiation (808 nm, 2.0 W cm<small><sup>−2</sup></small>), the 4T1 cancer cell viability was 65.8% or 76.8% when treated with mNiS<small><sub>2</sub></small> NSs or free CPT (the equivalent NS concentration was 20 μg mL<small><sup>−1</sup></small>), respectively. Satisfyingly, an obvious lower cell survival (30.7%) was observed when 4T1 cells were subjected to combined treatment of CPT@mNiS<small><sub>2</sub></small> NSs and NIR light illumination. In addition, a similar enhanced cell-killing effect was realized when HepG2 cancer cells were treated with CPT@mNiS<small><sub>2</sub></small> NSs plus NIR light illumination (Fig. S4, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), indicating the universality of the as-prepared CPT@mNiS<small><sub>2</sub></small> NSs for cancer cell elimination. Furthermore, the heat generated from CPT@mNiS<small><sub>2</sub></small> NSs under NIR laser irradiation could promote the intracellular uptake of CPT due to the accelerated metabolism and fluidity of the cell membrane (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>). For instance, upon treatment with 100 μg mL<small><sup>−1</sup></small> of CPT@mNiS<small><sub>2</sub></small> NSs and 5 min NIR laser irradiation, the generated heat could nearly double the amount of intracellular CPT in comparison to the group treated with free CPT (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6b</a>). Therefore, these data demonstrated that the mNiS<small><sub>2</sub></small> NSs prepared here were able to serve as a vehicle for loading hydrophobic cancer drugs to achieve a synergistic cancer cell-killing effect.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2019/TB/c8tb02473a/c8tb02473a-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8tb02473a-f6.tif" src="/image/article/2019/TB/c8tb02473a/c8tb02473a-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">Characterization of heat-promoted CPT uptake. (a) Fluorescence image of 4T1 cells; (b) quantitative analysis of the fluorescence intensity of intracellular CPT.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
    
    
      <h2 id="sect633"><span class="a_heading">Conclusions</span></h2>
      <span>In summary, degradable and monodispersed mNiS<small><sub>2</sub></small> NSs have been successfully prepared <span class="italic">via</span> a facile solvothermal method. Owing to considerable absorption in the NIR region, the as-prepared mNiS<small><sub>2</sub></small> NSs could be used as a potential PTT agent. Interestingly, a gradual oxidation and degradation performance could be observed when mNiS<small><sub>2</sub></small> NSs were exposed to a relatively high concentration of dissolved oxygen and H<small><sub>2</sub></small>O<small><sub>2</sub></small>, implying biosafety without long-term toxicological concerns. In addition, the mNiS<small><sub>2</sub></small> NSs possess large pore volume and high surface area which are beneficial for the efficient encapsulation of hydrophobic CPT, thus realizing an NIR laser responsive CPT release. Importantly, a synergistic cancer cell killing effect has been observed when 4T1 or HepG2 cancer cells were treated with CPT@mNiS<small><sub>2</sub></small> NSs and NIR laser irradiation simultaneously. Thus, our data have demonstrated the good potential of mNiS<small><sub>2</sub></small> NSs to act as a hydrophobic drug delivery vehicle for enhanced cell-killing efficiency through combined photothermal–chemotherapy.</span>
    
    
      <h2 id="sect645"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts to declare.</span>
    
  
    <h2 id="sect649"><span class="a_heading">Acknowledgements</span></h2>
      <span>This work was funded by the National Natural Science Foundation of China (no. 31500808; 81501590) and the Fundamental Research Funds for the Central Universities (no. JZ2018HGPA0273; JZ2018HGTB0247; JZ2018HGTA0202; and JZ2018HGBZ0156).</span>
    
    <span id="sect651"><h2 id="sect648"><span class="a_heading">Notes and references</span></h2></span><ol type="1">
      <li><span id="cit1">R. L. Siegel, K. D. Miller and A. Jemal, <span class="italic">Ca-Cancer J. Clin.</span>, 2016, <span class="bold">66</span>, 7–30 <a target="_blank" class="DOILink" href="https://doi.org/10.3322/caac.21332" title="DOI Link to resource 10.3322/caac.21332">CrossRef</a>.</span></li>
      <li><span id="cit2">A. Rider, S. Simpson, B. Bennett, K. Byrne, P. Hallworth, T. Desai and K. Cocks, <span class="italic">Ann. Oncol.</span>, 2017, 28 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Ann.%20Oncol.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%2028%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit3">V. Lambert-Obry, A. Gouault-Laliberte, A. Castonguay, G. Zanotti, T. Tran, M. Mates, J. Lemieux, P. Chabot, C. Prady, F. Couture and J. Lachaine, <span class="italic">Curr. Oncol.</span>, 2018, <span class="bold">25</span>, E282–E290 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BB3c7osFagug%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit4">D. P. Ferris, J. Lu, C. Gothard, R. Yanes, C. R. Thomas, J. C. Olsen, J. F. Stoddart, F. Tamanoi and J. I. Zink, <span class="italic">Small</span>, 2011, <span class="bold">7</span>, 1816–1826 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201002300" title="DOI Link to resource 10.1002/smll.201002300">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXotVOrsbY%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit5">V. Wagner, A. Dullaart, A. K. Bock and A. Zweck, <span class="italic">Nat. Biotechnol.</span>, 2006, <span class="bold">24</span>, 1211–1217 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nbt1006-1211" title="DOI Link to resource 10.1038/nbt1006-1211">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgsrvI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit6">J. Lu, M. Liong, J. I. Zink and F. Tamanoi, <span class="italic">Small</span>, 2007, <span class="bold">3</span>, 1341–1346 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.200700005" title="DOI Link to resource 10.1002/smll.200700005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXpt1aqtLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit7">J. Liu, Z. Jiang, S. Zhang and W. M. Saltzman, <span class="italic">Biomaterials</span>, 2009, <span class="bold">30</span>, 5707–5719 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2009.06.061" title="DOI Link to resource 10.1016/j.biomaterials.2009.06.061">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCnsr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19632718%5Buid%5D" title="PubMed Link to resource 19632718">PubMed</a>.</span></li>
      <li><span id="cit8">M. T. Morgan, Y. Nakanishi, D. J. Kroll, A. P. Griset, M. A. Carnahan, M. Wathier, N. H. Oberlies, G. Manikumar, M. C. Wani and M. W. Grinstaff, <span class="italic">Cancer Res.</span>, 2006, <span class="bold">66</span>, 11913–11921 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-06-2066" title="DOI Link to resource 10.1158/0008-5472.CAN-06-2066">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xhtlagu7vJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17178889%5Buid%5D" title="PubMed Link to resource 17178889">PubMed</a>.</span></li>
      <li><span id="cit9">M. Loredo-Tovias, A. Duran-Meza, M. Villagrana-Escareño, R. Vega-Acosta, E. Reynaga-Hernández, L. M. Flores-Tandy, O. Valdes-Resendiz, R. Cadena-Nava, E. Alvizo-Paez and J. Ruiz-Garcia, <span class="italic">Nanoscale</span>, 2017, <span class="bold">9</span>, 11625–11631 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7NR02118F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7NR02118F">RSC</a>.</span></li>
      <li><span id="cit10">F. Zhang, G. Zhu, O. Jacobson, Y. Liu, K. Chen, G. Yu, Q. Ni, J. Fan, Z. Yang and F. Xu, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 8838–8848 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b03003" title="DOI Link to resource 10.1021/acsnano.7b03003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWnu7nN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit11">C. Fuchs, E. P. Mitchell and P. M. Hoff, <span class="italic">Cancer Treat. Rev.</span>, 2006, <span class="bold">32</span>, 491–503 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ctrv.2006.07.001" title="DOI Link to resource 10.1016/j.ctrv.2006.07.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtVajsrfO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16959432%5Buid%5D" title="PubMed Link to resource 16959432">PubMed</a>.</span></li>
      <li><span id="cit12">K. S. Cunha, M. L. Reguly, U. Graf and H. H. Rodrigues de Andrade, <span class="italic">Mutagenesis</span>, 2002, <span class="bold">17</span>, 141–147 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/mutage/17.2.141" title="DOI Link to resource 10.1093/mutage/17.2.141">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XitlSqs74%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit13">A. N. C. Sortibrán, M. G. O. Téllez and R. Rodríguez-Arnaiz, <span class="italic">Mutat. Res., Genet. Toxicol. Environ. Mutagen.</span>, 2006, <span class="bold">604</span>, 83–90 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.mrgentox.2006.01.003" title="DOI Link to resource 10.1016/j.mrgentox.2006.01.003">CrossRef</a>.</span></li>
      <li><span id="cit14">P. Zhang, A. G. Cheetham, Y.-A. Lin and H. Cui, <span class="italic">ACS Nano</span>, 2013, <span class="bold">7</span>, 5965–5977 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn401667z" title="DOI Link to resource 10.1021/nn401667z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXptFeiu7s%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit15">H. Meng, M. Wang, H. Liu, X. Liu, A. Situ, B. Wu, Z. Ji, C. H. Chang and A. E. Nel, <span class="italic">ACS Nano</span>, 2015, <span class="bold">9</span>, 3540–3557 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b00510" title="DOI Link to resource 10.1021/acsnano.5b00510">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXksFSksbg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit16">D. Liu, W. Wu, X. Chen, S. Wen, X. Zhang, Q. Ding, G. Teng and N. Gu, <span class="italic">Nanoscale</span>, 2012, <span class="bold">4</span>, 2306–2310 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2NR11918H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2NR11918H">RSC</a>.</span></li>
      <li><span id="cit17">K. Dong, Z. Liu, Z. H. Li, J. S. Ren and X. G. Qu, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">25</span>, 4452–4458 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201301232" title="DOI Link to resource 10.1002/adma.201301232">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSht7zN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit18">S. P. Hudson, R. F. Padera, R. Langer and D. S. Kohane, <span class="italic">Biomaterials</span>, 2008, <span class="bold">29</span>, 4045–4055 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2008.07.007" title="DOI Link to resource 10.1016/j.biomaterials.2008.07.007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtVaisL3N" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18675454%5Buid%5D" title="PubMed Link to resource 18675454">PubMed</a>.</span></li>
      <li><span id="cit19">H. Wang, K. Wang, B. Tian, R. Revia, Q. Mu, M. Jeon, F. C. Chang and M. Zhang, <span class="italic">Small</span>, 2016, <span class="bold">12</span>, 6388–6397 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201602263" title="DOI Link to resource 10.1002/smll.201602263">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsFOmsL%252FM" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit20">H. P. Gerber and N. Ferrara, <span class="italic">Cancer Res.</span>, 2005, <span class="bold">65</span>, 671–680 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWnsb0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit21">N. Ibrahim, Y. Yu, W. R. Walsh and J. L. Yang, <span class="italic">Oncol. Rep.</span>, 2012, <span class="bold">27</span>, 1303–1311 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Squr0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit22">C.-M. J. Hu and L. Zhang, <span class="italic">Biochem. Pharmacol.</span>, 2012, <span class="bold">83</span>, 1104–1111 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bcp.2012.01.008" title="DOI Link to resource 10.1016/j.bcp.2012.01.008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiu7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22285912%5Buid%5D" title="PubMed Link to resource 22285912">PubMed</a>.</span></li>
      <li><span id="cit23">X. Wang, F. Li, X. Yan, Y. Ma, Z.-H. Miao, L. Dong, H. Chen, Y. Lu and Z. Zha, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 41782–41793 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.7b15780" title="DOI Link to resource 10.1021/acsami.7b15780">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqur7E" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit24">H. Chen, Y. Ma, X. Wang and Z. Zha, <span class="italic">J. Mater. Chem. B</span>, 2017, <span class="bold">5</span>, 7051–7058 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7TB01712J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7TB01712J">RSC</a>.</span></li>
      <li><span id="cit25">W. Chen, K. Zeng, H. Liu, J. Ouyang, L. Wang, Y. Liu, H. Wang, L. Deng and Y. N. Liu, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1605795 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201605795" title="DOI Link to resource 10.1002/adfm.201605795">CrossRef</a>.</span></li>
      <li><span id="cit26">X. Huang, W. Zhang, G. Guan, G. Song, R. Zou and J. Hu, <span class="italic">Acc. Chem. Res.</span>, 2017, <span class="bold">50</span>, 2529–2538 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.accounts.7b00294" title="DOI Link to resource 10.1021/acs.accounts.7b00294">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2js7zO" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit27">X. Huang, G. Deng, L. Liao, W. Zhang, G. Guan, F. Zhou, Z. Xiao, R. Zou, Q. Wang and J. Hu, <span class="italic">Nanoscale</span>, 2017, <span class="bold">9</span>, 2626–2632 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6NR09028A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6NR09028A">RSC</a>.</span></li>
      <li><span id="cit28">S. Shen, Y. Chao, Z. Dong, G. Wang, X. Yi, G. Song, K. Yang, Z. Liu and L. Cheng, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1700250 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201700250" title="DOI Link to resource 10.1002/adfm.201700250">CrossRef</a>.</span></li>
      <li><span id="cit29">Z. Zha, X. Yue, Q. Ren and Z. Dai, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">25</span>, 777–782 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201202211" title="DOI Link to resource 10.1002/adma.201202211">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GhurnM" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit30">W. Chen, J. Ouyang, H. Liu, M. Chen, K. Zeng, J. Sheng, Z. Liu, Y. Han, L. Wang and J. Li, <span class="italic">Adv. Mater.</span>, 2017, <span class="bold">29</span>, 1603864 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201603864" title="DOI Link to resource 10.1002/adma.201603864">CrossRef</a>.</span></li>
      <li><span id="cit31">Y. Zhang, D. Yang, H. Chen, W. Q. Lim, F. S. Z. Phua, G. An, P. Yang and Y. Zhao, <span class="italic">Biomaterials</span>, 2018, <span class="bold">163</span>, 14–24 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.02.023" title="DOI Link to resource 10.1016/j.biomaterials.2018.02.023">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXis1Orsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29452945%5Buid%5D" title="PubMed Link to resource 29452945">PubMed</a>.</span></li>
      <li><span id="cit32">A. Li Volsi, C. Scialabba, V. Vetri, G. Cavallaro, M. Licciardi and G. Giammona, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 14453–14469 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.7b03711" title="DOI Link to resource 10.1021/acsami.7b03711">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXlslCitbs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit33">W. Tian, Y. Su, Y. Tian, S. Wang, X. Su, Y. Liu, Y. Zhang, Y. Tang, Q. Ni and W. Liu, <span class="italic">Adv. Sci.</span>, 2017, <span class="bold">4</span>, 1600356 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201600356" title="DOI Link to resource 10.1002/advs.201600356">CrossRef</a>.</span></li>
      <li><span id="cit34">K. Mebrouk, M. Ciancone, T. Vives, S. Cammas-Marion, T. Benvegnu, C. Le Goff-Gaillard, Y. Arlot-Bonnemains, M. Fourmigué and F. Camerel, <span class="italic">ChemMedChem</span>, 2017, <span class="bold">12</span>, 1753–1758 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cmdc.201700344" title="DOI Link to resource 10.1002/cmdc.201700344">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2jur%252FK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit35">K. Jayaramulu, J. Masa, O. Tomanec, D. Peeters, V. Ranc, A. Schneemann, R. Zboril, W. Schuhmann and R. A. Fischer, <span class="italic">Adv. Funct. Mater.</span>, 2017, 27 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Funct.%20Mater.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%2027%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit36">R. Sun, S. Liu, Q. Wei, J. Sheng, S. Zhu, Q. An and L. Mai, <span class="italic">Small</span>, 2017, <span class="bold">13</span>, 1701744 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201701744" title="DOI Link to resource 10.1002/smll.201701744">CrossRef</a>.</span></li>
      <li><span id="cit37">H. Zhu, Z. Lai, Y. Fang, X. Zhen, C. Tan, X. Qi, D. Ding, P. Chen, H. Zhang and K. Pu, <span class="italic">Small</span>, 2017, <span class="bold">13</span>, 1604139 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201604139" title="DOI Link to resource 10.1002/smll.201604139">CrossRef</a>.</span></li>
      <li><span id="cit38">D. Gao, P. Zhang, C. Liu, C. Chen, G. Gao, Y. Wu, Z. Sheng, L. Song and L. Cai, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 17631–17636 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR05237H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR05237H">RSC</a>.</span></li>
      <li><span id="cit39">Z. Zhou, J. Wang, W. Liu, C. Yu, B. Kong, Y. Sun, H. Yang, S. Yang and W. Wang, <span class="italic">Nanoscale</span>, 2014, <span class="bold">6</span>, 12591–12600 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4NR03727H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4NR03727H">RSC</a>.</span></li>
      <li><span id="cit40">S. Bano, S. Nazir, S. Munir, M. F. AlAjmi, M. Afzal and K. Mazhar, <span class="italic">Int. J. Nanomed.</span>, 2016, <span class="bold">11</span>, 3159 <a target="_blank" class="DOILink" href="https://doi.org/10.2147/IJN.S106533" title="DOI Link to resource 10.2147/IJN.S106533">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFGmtr3M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27471383%5Buid%5D" title="PubMed Link to resource 27471383">PubMed</a>.</span></li>
      <li><span id="cit41">Q. Tian, F. Jiang, R. Zou, Q. Liu, Z. Chen, M. Zhu, S. Yang, J. Wang, J. Wang and J. Hu, <span class="italic">ACS Nano</span>, 2011, <span class="bold">5</span>, 9761–9771 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn203293t" title="DOI Link to resource 10.1021/nn203293t">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsVarsrrI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit42">Q. Tian, J. Hu, Y. Zhu, R. Zou, Z. Chen, S. Yang, R. Li, Q. Su, Y. Han and X. Liu, <span class="italic">J. Am. Chem. Soc.</span>, 2013, <span class="bold">135</span>, 8571–8577 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja4013497" title="DOI Link to resource 10.1021/ja4013497">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit43">K. Liu, X. Yan, Y.-J. Xu, L. Dong, L.-N. Hao, Y.-H. Song, F. Li, Y. Su, Y.-D. Wu and H.-S. Qian, <span class="italic">Biomater. Sci.</span>, 2017, <span class="bold">5</span>, 2403–2415 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7BM00797C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7BM00797C">RSC</a>.</span></li>
      <li><span id="cit44">Y. Cui, X. Lai, L. Li, Z. Hu, S. Wang, J. E. Halpert, R. Yu and D. Wang, <span class="italic">ChemPhysChem</span>, 2012, <span class="bold">13</span>, 2610–2614 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cphc.201100806" title="DOI Link to resource 10.1002/cphc.201100806">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yrtrbK" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit45">Z. Wan, C. Jia and Y. Wang, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 12737–12742 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR03054D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR03054D">RSC</a>.</span></li>
      <li><span id="cit46">T. Tian, L. Huang, L. Ai and J. Jiang, <span class="italic">J. Mater. Chem. A</span>, 2017, <span class="bold">5</span>, 20985–20992 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7TA06671F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7TA06671F">RSC</a>.</span></li>
      <li><span id="cit47">G. Song, J. Hao, C. Liang, T. Liu, M. Gao, L. Cheng, J. Hu and Z. Liu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 2122–2126 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201510597" title="DOI Link to resource 10.1002/anie.201510597">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXitVyqurfJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit48">L. Feng, K. Li, X. Shi, M. Gao, J. Liu and Z. Liu, <span class="italic">Adv. Healthcare Mater.</span>, 2014, <span class="bold">3</span>, 1261–1271 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201300549" title="DOI Link to resource 10.1002/adhm.201300549">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKjtrbJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit49">Y. Wang, J. Yang, H. Liu, X. Wang, Z. Zhou, Q. Huang, D. Song, X. Cai, L. Li, K. Lin, J. Xiao, P. Liu, Q. Zhang and Y. Cheng, <span class="italic">Biomaterials</span>, 2017, <span class="bold">114</span>, 97–105 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.11.010" title="DOI Link to resource 10.1016/j.biomaterials.2016.11.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhvVGqur%252FE" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit50">D. K. Roper, W. Ahn and M. Hoepfner, <span class="italic">J. Phys. Chem. C</span>, 2007, <span class="bold">111</span>, 3636–3641 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp064341w" title="DOI Link to resource 10.1021/jp064341w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynsrs%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit51">S.-M. Zhou, D.-K. Ma, S.-H. Zhang, W. Wang, W. Chen, S.-M. Huang and K. Yu, <span class="italic">Nanoscale</span>, 2016, <span class="bold">8</span>, 1374–1382 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR06041A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR06041A">RSC</a>.</span></li>
      <li><span id="cit52">C. M. Hessel, V. P. Pattani, M. Rasch, M. G. Panthani, B. Koo, J. W. Tunnell and B. A. Korgel, <span class="italic">Nano Lett.</span>, 2011, <span class="bold">11</span>, 2560–2566 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nl201400z" title="DOI Link to resource 10.1021/nl201400z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlvFClsbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21553924%5Buid%5D" title="PubMed Link to resource 21553924">PubMed</a>.</span></li>
      <li><span id="cit53">T. Bao, W. Yin, X. Zheng, X. Zhang, J. Yu, X. Dong, Y. Yong, F. Gao, L. Yan and Z. Gu, <span class="italic">Biomaterials</span>, 2016, <span class="bold">76</span>, 11–24 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2015.10.048" title="DOI Link to resource 10.1016/j.biomaterials.2015.10.048">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yktLfO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26517561%5Buid%5D" title="PubMed Link to resource 26517561">PubMed</a>.</span></li>
      <li><span id="cit54">H. Chen, Y. Ma, X. Wang, X. Wu and Z. Zha, <span class="italic">RSC Adv.</span>, 2017, <span class="bold">7</span>, 248–255 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6RA24979E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6RA24979E">RSC</a>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnotes</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available: Morphology of CPT@mNiS<small><sub>2</sub></small> NSs, the cell viability of HepG2 cancer cells, <span class="italic">etc.</span> See DOI: <a href="http://xlink.rsc.org/?DOI=c8tb02473a" target="_blank" title="Select to resolve DOI: 10.1039/c8tb02473a">10.1039/c8tb02473a</a></span></span></td></tr><tr><td><span class="sup_ref">‡ <span id="fn2">These authors contributed equally to this work.</span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>